In December 2009, the da Vinci® Surgical System was FDA approved for transoral robotic surgery (TORS) for tumors of the mouth, throat, and voice box. Intuitive has been very selective in its choice of surgeons to be among the first to offer TORS in the U.S. Through Drs. Huntley and Krowiak's work, CENTA is among the first dozen centers in the country to offer TORS, which brings many potential benefits to head and neck cancer patients. These include quicker return to normal speech and swallowing, significantly less pain and blood loss, less risk of wound infection, shorter hospital stays, shorter recovery times, and less scarring, compared to traditional treatment options. The need for chemotherapy and/or radiation therapy is potentially lessened with TORS, as is the need for a tracheostomy and a long-term feeding tube when compared to traditional surgery.
TORS allows access to areas surgically that, in the past, could only be achieved by splitting a patient's jaw and tongue. TORS allows this same surgery to be done through the mouth with no external excisions.
Drs. Huntley and Krowiak are actively involved in clinical research in TORS for throat cancer. Their experience is such that, within six months of starting their TORS program, Dr. Huntley was invited to lecture at an international congress of robotic surgeons, and he and Dr. Krowiak are in demand as proctors to other U.S. surgeons who wish to learn TORS techniques. If you have been diagnosed with cancer of the tonsils, tongue base, or throat, you deserve to be treated by the area's most experienced team, CENTA and the Midwest Center for Robotic Surgery.
At CENTA, our goal is to offer cutting-edge ENT techniques while still maintaining the compassionate physician-patient relationship so vital to quality care and positive outcomes. Each patient is important to us, and we consider it a privilege to serve their ENT healthcare needs.